Open AccessMucor in a Viral Land: A Tale of Two Pathogens
Author(s) -
Mrittika Sen,
Sumeet Lahane,
Tatyarao Lahane,
Ragini Parekh,
Santosh G Honavar
Publication year - 2021
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_3774_20
Subject(s) - medicine , mucormycosis , immunosuppression , retrospective cohort study , surgery , diabetes mellitus , debridement (dental) , amphotericin b , histopathology , dermatology , antifungal , pathology , endocrinology
COVID-19 infection, its treatment, resultant immunosuppression, and pre-existing comorbidities have made patients vulnerable to secondary infections including mucormycosis. It is important to understand the presentation, temporal sequence, risk factors, and outcomes to undertake measures for prevention and treatment.